Viracta Therapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Cardiff, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Viracta Therapeutics, Inc. has filed 1,181 SEC EDGAR filings since 07 Aug 2002

SEC filing history

Showing 451-475 of 861 matching filings.

Per page
25
Current page
19
CT ORDER File 000-51531

CT ORDER filing

Filing date
22 May 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-217849

FORM S-8

Filing date
10 May 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-51531

FORM 8-K

Filing date
08 May 2017
Reporting date
08 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-51531

FORM 8-K

Filing date
01 May 2017
Reporting date
01 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-51531

FORM 8-K

Filing date
28 Apr 2017
Reporting date
26 Apr 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
SC TO-C File 005-81034

PRELIMINARY COMMUNICATIONS

Filing date
20 Apr 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 000-51531

NOTICE & ACCESS

Filing date
20 Apr 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 000-51531

DEFINITIVE PROXY STATEMENT

Filing date
20 Apr 2017
Reporting date
31 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-51531

FORM 8-K

Filing date
12 Apr 2017
Reporting date
07 Apr 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
SC TO-C File 005-81034

PRELIMINARY COMMUNICATIONS

Filing date
03 Apr 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
PRE 14A File 000-51531

PRE 14A

Filing date
03 Apr 2017
Reporting date
31 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-51531

8-K

Filing date
27 Mar 2017
Reporting date
22 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-51531

8-K

Filing date
09 Mar 2017
Reporting date
09 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-81034

SC 13G/A filing

Filing date
14 Feb 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-81034

SC 13G/A filing

Filing date
14 Feb 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-81034

SC 13G/A

Filing date
14 Feb 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-81034

SC 13G/A filing

Filing date
14 Feb 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-81034

SC 13G filing

Filing date
14 Feb 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-81034

AMENDMENT NO. 3 TO THE SCHEDULE 13G

Filing date
14 Feb 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-81034

SC 13G/A filing

Filing date
13 Jan 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-81034

SCHEDULE 13G

Filing date
06 Jan 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4/A

FORM 4/A -

Filing date
16 Dec 2016
Reporting date
08 Dec 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
12 Dec 2016
Reporting date
08 Dec 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .